Company / Net Income
Aurinia Pharmaceuticals Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$287.2M
FY2025
5-year range
-$102.7M / $287.2M
FY2021-FY2025
Trend
+4893.1%
vs FY2024
Sector context
#28 of 216
Health Care
What the data says
Net Income changed +4893% YoY in FY2025, a notable deviation from the 7-year average annual change of +706%.
Based on SEC 10-K filings.
$287M in FY2025. Top quartile in the Health Care sector.
Improved from -$78M to $287M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 216This company $287.2M Sector average $454.1M
▼
-36.8% below sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s net income has grown for 3 consecutive years.
- In FY2025, net income increased 4893.1% year-over-year.
- Ranks #28 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $287.2M | +4893.1% |
| FY2024 | $5.8M | +107.4% |
| FY2023 | -$78.0M | +24.0% |
| FY2022 | -$102.7M | -16.2% |
| FY2021 | -$88.4M | +13.9% |
| FY2020 | -$102.7M | -16.2% |
| FY2019 | -$88.4M | -66.5% |
| FY2018 | -$53.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026